Breaking News Instant updates and real-time market news.

WMT

Walmart

$84.40

1.03 (1.24%)

, TEVA

Teva

$20.37

1.07 (5.54%)

07:35
05/15/18
05/15
07:35
05/15/18
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Monday in Wal-Mart (WMT), Teva (TEVA), Time Warner (TWX), Devon Energy (DVN), Barrick Gold (ABX), Symantec (SYMC), Procter & Gamble (PG), Caesars (CZR), First Solar (FSLR), and GameStop (GME).

WMT

Walmart

$84.40

1.03 (1.24%)

TEVA

Teva

$20.37

1.07 (5.54%)

TWX

Time Warner

$94.34

0.55 (0.59%)

DVN

Devon Energy

$41.31

0.36 (0.88%)

ABX

Barrick Gold

$13.48

-0.025 (-0.19%)

SYMC

Symantec

$21.40

1.89 (9.69%)

PG

Procter & Gamble

$73.29

-0.08 (-0.11%)

CZR

Caesars

$12.50

0.6 (5.04%)

FSLR

First Solar

$73.54

0.75 (1.03%)

GME

GameStop

$13.25

0.55 (4.33%)

  • 15

    May

  • 15

    May

  • 15

    May

  • 17

    May

  • 18

    May

  • 22

    May

  • 22

    May

  • 30

    May

  • 01

    Jun

  • 05

    Jun

  • 07

    Jun

  • 16

    Jun

WMT Walmart
$84.40

1.03 (1.24%)

05/10/18
DBAB
05/10/18
NO CHANGE
Target $87
DBAB
Hold
Walmart price target lowered to $87 from $99 at Deutsche Bank
Deutsche Bank analyst Paul Trussell lowered his price target for Walmart to $87 ahead of the company's Q1 results on May 17. The analyst keeps a Hold rating on the shares. Investors are expressing concerns around management's ability to re-accelerate U.S. online growth, which yesterday's "dilutive" Flipkart deal exacerbated, Trussell tells investors in a research note.
05/10/18
RBCM
05/10/18
NO CHANGE
Target $88
RBCM
Sector Perform
Walmart price target lowered to $88 from $103 at RBC Capital
RBC Capital analyst Scot Ciccarrelli lowered his price target on Walmart and kept his Sector Perform rating after its $16B investment for a 77% stake in Flipkart. The analyst contends that while the stake marks a "beachhead in one of the highest growth potential markets on the globe", which could also lead to a liquidity opportunity through a Flipkart IPO longer term, the operating loss from the capital deployment may be "material".
05/10/18
MSCO
05/10/18
NO CHANGE
Target $93
MSCO
Equal Weight
Walmart deal for Flipkart more dilutive than anticipated, says Morgan Stanley
Morgan Stanley analyst Simeon Gutman noted that news reports heading up to Walmart's (WMT) deal for a majority stake in Flipkart had predicted a $12B transaction for about 60% of a business generating operating losses in the $1B range. However, the higher than expected magnitude of losses Walmart would absorb in India significantly raises the stakes on the trajectory of its U.S. business and clouds the near-term path, he said. He also questions why the company is investing outside the U.S. market, stating that it could have instead accelerated its third-party marketplace infrastructure, stepped up its partnership with Google Home (GOOG) to better compete with Amazon's (AMZN) Alexa, or intensified domestic investments in price and fulfillment. However, he does add that the deal prevents Amazon, for now, from building an "insurmountable" advantage in the important Indian market. Gutman lowered his price target on Walmart to $93 from $99 after the deal was more dilutive than anticipated and keeps an Equal Weight rating on the shares.
05/10/18
LOOP
05/10/18
NO CHANGE
Target $87
LOOP
Hold
Walmart price target lowered to $87 from $92 at Loop Capital
Loop Capital analyst Andrew Wolf lowered his price target on Walmart to $87 and kept his Hold rating after the company's $16B investment in Flipkart. The analyst is positive on the deal longer term, given that India's retail market is expected to grow at 9% per year over the next 5 years and in light of the company's minimal store presence in India. In the medium term however, Wolf says the investment will be "meaningfully dilutive" to earnings, weighing on the stock.
TEVA Teva
$20.37

1.07 (5.54%)

04/30/18
DBAB
04/30/18
NO CHANGE
Target $22
DBAB
Buy
Deutsche raises Valeant price target on extended Xifaxan exclusivity
The stay in the Xifaxan litigation between Valeant Pharmaceuticals (VRX) and Teva (TEVA) was recently extended to July 30, 2018 from April 30, 2018, and may be extended further, Deutsche Bank analyst Gregg Gilbert tells investors in an intraday research note. According to the court docket, the companies agreed to extend the stay "because the facts and circumstances that warranted a stay as of May 15, 2017 have not materially changed," Gilbert adds. He previously modeled Xifaxan exclusivity through 2024, but pushed that out one more year saying Teva "does not yet appear to have clarity on the path forward for its generic filing." The exclusivity extension to 2025 on Valeant's largest product pushes the analyst's price target for the shares to $22 from $20. The stock in midday trading is up 19c to $18.26. Gilbert looks forward to an update from Teva when the company reports on May 3 and continues to like the risk/reward for Valeant. He keeps a Buy rating on the shares.
05/03/18
WELS
05/03/18
NO CHANGE
Target $16.5
WELS
Underperform
Teva Q1 'just what investors wanted,' says Wells Fargo
Wells Fargo analyst David Maris believes this quarter is exactly the quarter investors wanted out of Teva, namely progress on the cost cutting and raised guidance on the back of a business that is still facing a significant decline given a tough U.S. generics environment and generic Copaxone pressures. The analyst reiterates an Underperform rating and $16.50 price target on the shares.
05/07/18
FBCO
05/07/18
NO CHANGE
Target $23
FBCO
Outperform
Teva turnaround story appears generally on track, says Credit Suisse
Credit Suisse analyst Vamil Divan believes Teva's Q1 earnings were "solid" and sees his bullish thesis on the company as being on track. The analyst notes that the company's restructuring program is proceeding in line with its prior guidance and his expectations, if even a bit ahead of schedule. Divan reiterates an Outperform rating and $23 price target on the shares.
04/27/18
JEFF
04/27/18
NO CHANGE
Target $105
JEFF
Buy
Neurocrine's Ingrezza can beat Q1 estimates, says Jefferies
Jefferies analyst Biren Amin says his firm's fifth proprietary survey on tardive dyskinesia reaffirms that Neurocrine Biosciences' (NBIX) Ingrezza is leading Teva's (TEVA) Austedo in market share for both moderate-severe and mild cases. The analyst thinks Ingrezza can modestly beat consensus estimates for Q1. He keeps a Buy rating on Neurocrine shares with a $105 price target.
TWX Time Warner
$94.34

0.55 (0.59%)

03/23/18
WELS
03/23/18
NO CHANGE
Target $40
WELS
Outperform
AT&T price target lowered to $40 from $48 Wells Fargo
Wells Fargo analyst Jennifer Fritzsche lowered her price target for AT&T (T) to $40 from $48 given recent volatility and uncertainty around Time Warner (TWX) path. Nonetheless, the analyst reiterates an Outperform rating on AT&T shares and believes Q1 2018 will represent the second consecutive quarter of positive handset ads for the company.
05/02/18
BRRR
05/02/18
NO CHANGE
Target $110
BRRR
Outperform
Odds in favor of Time Warner deal closing, says Barrington
Barrington analyst James Goss said he continues to expect the acquisition of Time Warner (TWX) by AT&T (T) to ultimately gain court approval and his Outperform rating in part reflects the significant gap from the AT&T takeout offer. He also sees relatively modest downside risk in the event of the deal being blocked, given the continued fundamental support based on existing Time Warner assets and operations, he tells investors. Goss maintains a $110 price target on Time Warner shares.
04/17/18
PIVT
04/17/18
DOWNGRADE
Target $105
PIVT
Hold
Time Warner downgraded to Hold from Buy at Pivotal Research
Pivotal Research analyst Brian Wieser downgraded Time Warner (TWX) to Hold and lowered his price target for the shares to $105 from $108. The stock's value is driven by current trading levels of AT&T (T) under a presumption that the sale of the company goes through, Wieser tells investors in a research note.
04/11/18
JEFF
04/11/18
NO CHANGE
JEFF
T-Mobile, Sprint deal has more hurdles than AT&T, Time Warner, says Jefferies
A horizontal merger between T-Mobile (TMUS) and Sprint (S) poses more significant regulatory hurdles than the contested AT&T (T), Time Warner (TWX) deal does, Jefferies analyst Scott Goldman tells investors in a research note after the Wall Street Journal reported the two companies are again in merger talks. The analyst believes potential regulatory remedies could include meaningful spectrum divestitures. With that said, he thinks the combined company would create "meaningful accretion," with free cash flow per share nearly 30% higher in year three. Using multiple analysis, Goldman thinks T-Mobile shares could be worth more than $88 in a deal scenario. The stock closed yesterday up 3.4% to $63.13. Further, the analyst recommends buying the tower stocks on yesterday's selloff given his view of significant regulatory hurdles for a Sprint, T-Mobile deal. He has Buy ratings on American Tower (AMT), Crown Castle (CCI) and SBA Communications (SBAC).
DVN Devon Energy
$41.31

0.36 (0.88%)

03/07/18
UBSW
03/07/18
INITIATION
Target $35
UBSW
Neutral
Devon Energy initiated with a Neutral at UBS
UBS analyst Lloyd Byrne started Devon Energy with a Neutral rating and $35 price target.
05/08/18
SBSH
05/08/18
NO CHANGE
SBSH
Citi moves Pioneer Natural to top pick in large-cap E&P
Following Devon Energy's (DVN) recent outperformance, Citi analyst Robert Morris moves Pioneer Natural Resources (PXD) up to his top pick in large-cap Exploration & Production. The analyst views the recent pullback in shares of Pioneer Natural as a buying opportunity. Devon remains his second to pick in the space.
04/12/18
04/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Paycom (PAYC) downgraded to Equal Weight from Overweight at Barclays with analyst Raimo Lenschow saying the stock has meaningfully outperformed over the last year while estimate revisions have been limited. 2. J.B. Hunt (JBHT) downgraded to Sector Weight from Overweight at KeyBanc. 3. Devon Energy (DVN) downgraded to Outperform from Focus List at Scotia Howard Weil. 4. PJT Partners (PJT) downgraded to Hold from Buy at Sandler O'Neill with analyst Sumeet Mody saying after appreciating 17% year-to-date, the stock is approaching fair value. 5. Bed Bath & Beyond (BBBY) downgraded to Underperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/18
HOWW
04/12/18
DOWNGRADE
HOWW
Outperform
Devon Energy downgraded to Outperform from Focus List at Scotia Howard Weil
ABX Barrick Gold
$13.48

-0.025 (-0.19%)

04/23/18
ADAM
04/23/18
DOWNGRADE
ADAM
Hold
Barrick Gold downgraded to Hold from Buy at Canaccord
03/12/18
RBCM
03/12/18
UPGRADE
RBCM
Outperform
Barrick Gold upgraded to Outperform from Sector Perform at RBC Capital
03/12/18
RBCM
03/12/18
UPGRADE
Target $16
RBCM
Outperform
Barrick Gold upgraded to Outperform at RBC Capital on 'relative value'
As reported earlier, RBC Capital analyst Stephen Walker upgraded Barrick Gold to Outperform from Sector Perform, saying the impact of the company's higher cost guidance has been priced in while the current valuation offers an attractive entry point. The analyst also sees the resolution of the Acacia mine dispute and production updates as potential near term catalysts. Walker trims his price target on Barrick Gold to $16 from $17.
03/02/18
ARGS
03/02/18
DOWNGRADE
ARGS
Hold
Barrick Gold downgraded to Hold from Buy at Argus
As reported earlier, Argus analyst David Coleman downgraded Barrick Gold to Hold from Buy, stating that despite the sharp decline in the stock price this year, earnings are likely to remain flat or decline further in the coming quarters. Coleman points to the company's recent lower production forecast along with the likelihood of higher near term extraction costs, along with its ongoing tax dispute with the government of Tanzania where it operates the Acacia mines. In the long run, Coleman still expects Barrick Gold earnings to recover on "stable to modestly higher gold prices" and continued debt reduction efforts.
SYMC Symantec
$21.40

1.89 (9.69%)

05/11/18
MSCO
05/11/18
NO CHANGE
Target $26
MSCO
Equal Weight
Morgan Stanley says Symantec 'too hot to handle' given investigation uncertainty
After Symantec's FY19 guidance came in well below consensus expectations and "perhaps more concerning" the company announced an unspecified audit committee investigation, Morgan Stanley analyst Keith Weiss called the stock "too hot to handle" given that the matter was said to preclude the management team from taking any questions from analysts, either publicly or privately. Weiss, who thinks the investigation will likely remain an open question for some time, lowered his price target on the stock to $26 from $31 and keeps an Equal Weight rating on Symantec shares.
05/11/18
05/11/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Kohl's (KSS) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Binetti saying he sees first quarter same store sales risk due to cold weather damaging industry traffic and Kohl's being more weather sensitive than its peers, and slightly lowered his Q1 EPS estimate on the stock. 2. Symantec (SYMC) downgraded to Sell from Neutral at MoffettNathanson, to Equal Weight from Overweight at Barclays and First Analysis, to Perform from Outperform at Oppenheimer, and to Neutral from Buy at BTIG, to Neutral from Outperform at Macquarie, and to Neutral from Overweight at Piper Jaffray. 3. AMC Networks (AMCX) downgraded to In Line on valuation at Evercore ISI with analyst David Joyce citing valuation. 4. L Brands (LB) downgraded to Neutral from Overweight at Atlantic Equities. 5. Presidio (PSDO) downgraded to Sector Perform from Outperform at RBC Capital and to Market Perform from Outperform at Wells Fargo. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/18
JEFF
05/15/18
UPGRADE
Target $22
JEFF
Hold
Symantec upgraded to Hold from Underperform at Jefferies
Jefferies analyst John DiFucci upgraded Symantec to Hold and raised his price target for the shares to $22 from $20. While difficult, if not impossible, to assess the outcome of the current investigation, there's a base value for the business that is not far from the current price, DiFucci tells investors in a research note. He points out, however, that it "remains unclear whether the company will return to growth."
05/15/18
DBAB
05/15/18
NO CHANGE
Target $22
DBAB
Hold
Symantec call lessened near-term risk, says Deutsche Bank
The belated Q&A call hosted by Symantec, where management said they are not expecting a material adverse impact on the company's financials from the audit investigation, lessened the near-term risk, Deutsche Bank analyst Karl Keirstead tells investors in a research note. The analyst believes, however, that the audit probe risk will linger. Nonetheless, he concludes that the debate will now pivot to the likelihood of Symantec hitting "what looks like aggressive" fiscal 2020 targets. Keirstead keeps a Hold rating on the shares with a $22 price target.
PG Procter & Gamble
$73.29

-0.08 (-0.11%)

04/20/18
ARGS
04/20/18
DOWNGRADE
ARGS
Hold
Procter & Gamble downgraded to Hold at Argus on limited organic growth recovery
As reported earlier, Argus analyst John Staszak downgraded Procter & Gamble to Hold from Buy, saying organic growth has not improved to the expected extent even after the company spun off its Beauty and other businesses in recent years. Staszak adds P&G continues to lose market share to "fierce" competition, while its margin expansion has also slowed. The analyst sees the current valuation multiple of 17.7-times his FY18 EPS view as fair, but adds he would consider a more constructive stance if organic growth accelerated.
04/20/18
04/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Neutral from Buy at BofA/Merrill and to Hold from Buy at Deutsche Bank aw well as Argus. 2. Philip Morris (PM) downgraded to Buy from Conviction Buy at Goldman Sachs and to Underperform from Neutral at BofA/Merrill. 3. DHT Holdings (DHT) downgraded to Neutral from Overweight at JPMorgan with analyst Noah Parquette saying he has become more constructive on a crude tanker recovery in 2019 but cites relative valuation for the downgrade on DHT. 4. Skechers (SKX) downgraded to Neutral from Outperform at Wedbush with analyst Christopher Svezia citing the company's first quarter results. 5. Tyson Foods (TSN) downgraded to Hold from Buy at Vertical Group. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/20/18
ARGS
04/20/18
DOWNGRADE
ARGS
Hold
Procter & Gamble downgraded to Hold from Buy at Argus
04/20/18
RHCO
04/20/18
NO CHANGE
Target $75
RHCO
Hold
Procter & Gamble price target lowered to $75 from $90 at SunTrust
SunTrust analyst William Chappell lowered his price target on Procter & Gamble to $75 after the company's in-line Q3 earnings and updated guidance. Chappell says the continued success of Laundry, Beauty, and Health Care segments are encouraging, but also sees "little visibility" on when he can expect Baby and Grooming segments' pricing environment to improve. The analyst keeps his Hold rating on Procter & Gamble amid ongoing issues in the Baby, Feminine & Family Care segment, with Q1 growth down 3% driven by 2% decline in volume and 1% decline in price.
CZR Caesars
$12.50

0.6 (5.04%)

04/13/18
JEFF
04/13/18
NO CHANGE
JEFF
Jefferies sees opportunity in smid-cap casino stocks after selloff
The recent selloff in smid-cap casino stocks has been driven by the impact of severe weather in the regional markets as well as a challenging quarter in Las Vegas, Jefferies analyst David Katz tells investors in a research note. Following the release of positive March gross gaming revenue from several important regional markets, the context for the quarter is more positive, Katz adds. He believes the share selloff is overdone and presents opportunities in Caesars (CZR) and Penn National Gaming (PENN), among others.
04/05/18
NOMU
04/05/18
NO CHANGE
Target $15
NOMU
Buy
Nomura sees 'several' positive catalysts to reverse Caesars sentiment
Nomura Instinet analyst Harry Curtis sees "several" positive catalysts that could reverse the negative sentiment on shares of Caesars. These include Q2 RevPAR strength in Las Vegas, which is being underappreciated by investors, Curtis tells investors in a research note. He notes the stock has 36% upside potential to his $15 price target along with a 13% free cash flow yield on 2019 estimates. Curtis keeps a Buy rating on Caesars.
05/14/18
JEFF
05/14/18
NO CHANGE
JEFF
Jefferies says Penn National, Caesars among winners from sports gaming ruling
After the Supreme Court ruled that the PASPA provision prohibiting state authorization of organized sports gambling violates the tenth amendment, Jefferies analyst David Katz reiterated his view on which companies are positioned to be key beneficiaries of the decision. He continues to identify Penn National (PENN) and Caesars (CSR) as among the top winners in terms of casino operators, followed by Eldorado Resorts (ERI), Churchill Downs (CHDN), Boyd Gaming (BYD), Monarch Casino (MCRI), and MGM Resorts (MGM). He also sees "location-agnostic" suppliers Scientific Games (SGMS) and International Game (IGT) as winners, Katz tells investors.
03/07/18
NOMU
03/07/18
UPGRADE
NOMU
Buy
Caesars upgraded to Buy from Neutral at Nomura Instinet
FSLR First Solar
$73.54

0.75 (1.03%)

05/10/18
JPMS
05/10/18
UPGRADE
Target $85
JPMS
Overweight
JPMorgan upgrades First Solar to Overweight with $85 price target
JPMorgan analyst Paul Coster upgraded First Solar to Overweight from Neutral and raised his price target for the shares to $85 from $74. The shares closed yesterday up $2.17 to $69.43. The analyst believes investors need to take a "tactical view" of owning First Solar shares, buying and selling the stock within a $60-$110 range through the end of 2019. With the shares closer to the lower-end of that range, he's upgrading the name to Overweight. First Solar is arguably the "best-in-class company and the highest-quality stock in the solar module space," but its earnings growth is range-bound by the absence of pricing power in a global commodity market, Coster tells investors in a research note. The analyst, however, also sees "strong industry-wide unit growth for the foreseeable future and excellent revenue and earnings visibility" at the company.
05/10/18
JPMS
05/10/18
UPGRADE
Target $85
JPMS
Overweight
First Solar upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Paul Coster upgraded First Solar to Overweight and raised his price target for the shares to $85 from $74.
04/30/18
UBSW
04/30/18
NO CHANGE
Target $94
UBSW
Buy
First Solar price target raised to $94 from $81 at UBS
UBS analyst Jon Windham raised his price target on First Solar to $94 from $81 following strong Q1 results. The analyst believes the manufacturing expansion is positive and is indicative of strong existing forward bookings. Windham reiterated his Buy rating on First Solar shares.
04/23/18
ROTH
04/23/18
NO CHANGE
Target $90
ROTH
Buy
First Solar price target raised to $90 from $80 at Roth Capital
Roth Capital analyst Philip Shen raised his price target for First Solar to $90 from $80 ahead of quarterly results. The analyst reiterates a Buy rating on the shares.
GME GameStop
$13.25

0.55 (4.33%)

04/03/18
04/03/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Commercial Metals (CMC) downgraded to Neutral from Buy at Citi analyst Alexander Hacking saying multiple new rebar projects announced in recent months will offset the benefit of lower imports. 2. GameStop (GME) downgraded to Hold from Buy at Loop Capital with analyst Anthony Chukumba saying while the company's core video game business improved in fiscal 2017, its Technology Brands "dramatically underperformed," and collectibles sales missed expectations. 3. Manpower (MAN) downgraded to Underweight from Equal Weight at Barclays with analyst Manav Patnaik saying he believes good news is reflected in the current valuation and he expects Manpower to underperform its Temp Staffing peers. 4. Cancer Genetics (CGIX) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's "disappointing" fourth quarter revenues and what he views as a lack of strategic direction at the company. 5. Weatherford (WFT) downgraded to Neutral from Overweight at Piper Jaffray with analyst Bill Herbert saying the company's turnaround is taking longer than expected, and its balance sheet is "prodigiously heavy." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/03/18
LOOP
04/03/18
DOWNGRADE
Target $14
LOOP
Hold
GameStop downgraded to Hold from Buy at Loop Capital
Loop Capital analyst Anthony Chukumba downgraded GameStop to Hold and cut his price target for the shares to $14 from $26. The shares closed yesterday up 20c to $12.82. While the company's core video game business improved in fiscal 2017, its Technology Brands "dramatically underperformed," and collectibles sales missed expectations, Chukumba tells investors in a research note. The analyst is concerned with GameStop's declining sales and profitability in pre-owned and value video game products and believes management's reluctance to repurchase stock "sends a worrisome signal to investors." He sees a "lack of positive catalysts on the horizon" for the shares.
05/11/18
LOOP
05/11/18
NO CHANGE
Target $14
LOOP
Hold
Loop Capital keeps Hold rating on GameStop after 'surprising' CEO resignation
Loop Capital analyst Anthony Chukumba said he was "very surprised" by news of the resignation of Michael Mauler as CEO of GameStop, especially given he had been in the job for just over three months and the company previously "cleaned house" when he was installed at the top. Despite the fact that "management turmoil is the last thing GameStop needs" right now, Chukumba maintains a Hold rating on the shares, citing the "almost unheard of" 1.9x enterprise value/EBITDA multiple at which the stock now trades.
05/11/18
BARD
05/11/18
NO CHANGE
Target $18
BARD
Outperform
GameStop CEO change could push board to consider alternatives, says Baird
After GameStop announced the resignation of CEO Mike Mauler and appointment of long-time executive and executive chairman Dan DeMatteo as interim CEO, Baird analyst Colin Sebastian said he does not believe the change will impact the company's strategic direction. He also thinks that another CEO transition could push the board to consider strategic alternatives, especially given that the share price is not reflecting much confidence in the current operations. Sebastian maintains an Outperform rating and $18 price target on GameStop.

TODAY'S FREE FLY STORIES

KORS

Michael Kors

$68.63

0.25 (0.37%)

, LULU

Lululemon

$106.18

-0.19 (-0.18%)

11:07
05/26/18
05/26
11:07
05/26/18
11:07
Periodicals
Dollar Tree looks interesting, Barron's says »

Next week, another 20…

KORS

Michael Kors

$68.63

0.25 (0.37%)

LULU

Lululemon

$106.18

-0.19 (-0.18%)

GME

GameStop

$12.64

-0.1 (-0.78%)

DLTR

Dollar Tree

$95.23

0.59 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 31

    May

  • 31

    May

  • 12

    Jun

  • 14

    Jun

  • 26

    Jun

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

, QCOM

Qualcomm

$59.95

0.85 (1.44%)

10:58
05/26/18
05/26
10:58
05/26/18
10:58
Periodicals
Kraft Heinz, J&J among safe, 'solid' dividend stocks, Barron's says »

Kraft Heinz (KHC),…

KHC

Kraft Heinz

$57.78

0.72 (1.26%)

QCOM

Qualcomm

$59.95

0.85 (1.44%)

MRK

Merck

$59.08

-0.03 (-0.05%)

TGT

Target

$71.22

0.28 (0.39%)

OMC

Omnicom

$71.98

-0.1 (-0.14%)

CCL

Carnival

$64.27

0.12 (0.19%)

JNJ

Johnson & Johnson

$121.40

0.06 (0.05%)

MMM

3M

$198.98

-0.38 (-0.19%)

LLY

Eli Lilly

$82.75

0.05 (0.06%)

VLO

Valero

$118.81

-3.06 (-2.51%)

EMR

Emerson

$72.50

-0.77 (-1.05%)

WBA

Walgreens Boots Alliance

$63.52

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

  • 30

    May

  • 02

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 12

    Jun

  • 19

    Jun

  • 10

    Sep

  • 23

    Oct

MU

Micron

$61.33

-0.15 (-0.24%)

10:48
05/26/18
05/26
10:48
05/26/18
10:48
Periodicals
Micron can solve low valuation, Barron's says »

Micron's stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ATUS

Altice USA

$18.50

-0.05 (-0.27%)

10:40
05/26/18
05/26
10:40
05/26/18
10:40
Periodicals
Altice's spinoff could be winning bet, Barron's says »

On June 8, Altice will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 30

    May

MU

Micron

$61.33

-0.15 (-0.24%)

, XLNX

Xilinx

$69.63

0.88 (1.28%)

10:35
05/26/18
05/26
10:35
05/26/18
10:35
Periodicals
AI revolution just getting started, Barron's says »

Artificial Intelligence…

MU

Micron

$61.33

-0.15 (-0.24%)

XLNX

Xilinx

$69.63

0.88 (1.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 20

    Jun

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, DDAIF

Daimler AG

$0.00

(0.00%)

08:08
05/26/18
05/26
08:08
05/26/18
08:08
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

HMC

Honda

$32.04

-0.34 (-1.05%)

NSANY

Nissan

$0.00

(0.00%)

F

Ford

$11.51

-0.11 (-0.95%)

GM

General Motors

$38.30

-0.09 (-0.23%)

TM

Toyota

$129.97

-2.47 (-1.87%)

VLKAY

Volkswagen

$0.00

(0.00%)

BAC

Bank of America

$30.16

-0.03 (-0.10%)

C

Citi

$68.42

-0.86 (-1.24%)

GS

Goldman Sachs

$235.05

-1.1 (-0.47%)

JPM

JPMorgan

$110.62

-0.64 (-0.58%)

MS

Morgan Stanley

$53.02

-0.96 (-1.78%)

USB

U.S. Bancorp

$50.54

-0.14 (-0.28%)

WFC

Wells Fargo

$54.91

0.25 (0.46%)

TWTR

Twitter

$33.64

0.11 (0.33%)

AA

Alcoa

$47.92

-1.26 (-2.56%)

CENX

Century Aluminum

$16.27

-0.07 (-0.43%)

AOBC

American Outdoor Brands

$12.53

0.05 (0.40%)

RGR

Sturm, Ruger

$63.10

0.5 (0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 30

    May

  • 01

    Jun

  • 06

    Jun

  • 20

    Jun

  • 22

    Jun

  • 13

    Jul

  • 27

    Jul

  • 10

    Sep

  • 12

    Oct

  • 14

    Jan

  • 15

    Apr

  • 15

    Jul

  • 15

    Oct

HCLP

Hi-Crush Partners

$13.20

-0.825 (-5.88%)

17:54
05/25/18
05/25
17:54
05/25/18
17:54
Hot Stocks
Hi-Crush Partners provides update on bulldozer incident in Whitehall facility »

Hi-Crush Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$77.98

1.49 (1.95%)

17:37
05/25/18
05/25
17:37
05/25/18
17:37
Hot Stocks
Post Holdings reports fire in Michael Foods' plant in Pennsylvania »

Post Holdings reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:34
05/25/18
05/25
17:34
05/25/18
17:34
Hot Stocks
Abiomed to enter S&P 500 index on May 31 »

S&P MidCap 400…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

PRAH

PRA Health

$81.19

0.33 (0.41%)

GME

GameStop

$12.64

-0.1 (-0.78%)

FRED

Fred's

$1.69

0.05 (3.05%)

PRSP

Symbol now PB

$0.00

(0.00%)

RRTS

Roadrunner

$2.19

0.04 (1.86%)

DXC

DXC Technology

$94.20

-5.42 (-5.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 31

    May

  • 05

    Jun

  • 12

    Jun

PRAH

PRA Health

$81.19

0.33 (0.41%)

, ABMD

Abiomed

$394.49

0.04 (0.01%)

17:24
05/25/18
05/25
17:24
05/25/18
17:24
Hot Stocks
Breaking Hot Stocks news story on PRA Health, Abiomed »

PRA Health to replace…

PRAH

PRA Health

$81.19

0.33 (0.41%)

ABMD

Abiomed

$394.49

0.04 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

WYN

Wyndham

$107.98

-0.58 (-0.53%)

, MSCC

Microsemi

$68.74

0.005 (0.01%)

17:23
05/25/18
05/25
17:23
05/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Wyndham, Microsemi »

Wyndham to replace…

WYN

Wyndham

$107.98

-0.58 (-0.53%)

MSCC

Microsemi

$68.74

0.005 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$394.49

0.04 (0.01%)

, WYN

Wyndham

$107.98

-0.58 (-0.53%)

17:21
05/25/18
05/25
17:21
05/25/18
17:21
Hot Stocks
Breaking Hot Stocks news story on Abiomed, Wyndham »

ABIOMED to replace…

ABMD

Abiomed

$394.49

0.04 (0.01%)

WYN

Wyndham

$107.98

-0.58 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

  • 12

    Jun

PCG

PG&E

$44.67

0.84 (1.92%)

17:16
05/25/18
05/25
17:16
05/25/18
17:16
Periodicals
CA Forestry Dept rules PG&E equipment responsible for wildfires, Bloomberg says »

Report filed by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FARM

Farmer Bros.

$28.50

0.15 (0.53%)

17:09
05/25/18
05/25
17:09
05/25/18
17:09
Hot Stocks
Levin Capital Strategies reports 8.4% stake in Farmer Bros »

Levin Capital purchased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:07
05/25/18
05/25
17:07
05/25/18
17:07
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$1.22

-0.125 (-9.29%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Hot Stocks
Windstream completes one-for-five reverse stock split »

Windstream completed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDLS

Noodles & Company

$8.90

-0.35 (-3.78%)

17:06
05/25/18
05/25
17:06
05/25/18
17:06
Syndicate
Breaking Syndicate news story on Noodles & Company »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPD

Enterprise Products

$27.87

-0.12 (-0.43%)

17:01
05/25/18
05/25
17:01
05/25/18
17:01
Hot Stocks
Enterprise Products conduts open season for West Texas Crude oil expansion »

Enterprise Products…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INO

Inovio

$4.89

0.06 (1.24%)

16:37
05/25/18
05/25
16:37
05/25/18
16:37
Syndicate
Breaking Syndicate news story on Inovio »

Inovio files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$10.14

0.13 (1.30%)

16:36
05/25/18
05/25
16:36
05/25/18
16:36
Hot Stocks
Rent-A-Center 16.8% shareholder Engaged Capital nominates Carol McFate to Board »

On May 25, 2018, Engaged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKER

Akers Biosciences

$0.59

0.0086 (1.48%)

16:34
05/25/18
05/25
16:34
05/25/18
16:34
Hot Stocks
Akers Biosciences receives delinquency notice from NASDAQ »

Akers Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$6.60

0.37 (5.94%)

16:31
05/25/18
05/25
16:31
05/25/18
16:31
Hot Stocks
Ditech discloses receipt of late filing notice from NYSE »

Ditech Holding announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$28.15

-4.82 (-14.62%)

, FL

Foot Locker

$55.97

9.585 (20.67%)

16:30
05/25/18
05/25
16:30
05/25/18
16:30
General news
On The Fly: Top stock stories for Friday »

Stocks on Wall Street…

GPS

Gap

$28.15

-4.82 (-14.62%)

FL

Foot Locker

$55.97

9.585 (20.67%)

HLF

Herbalife Nutrition

$48.76

-5.09 (-9.45%)

IEP

Icahn Enterprises

$69.41

0.22 (0.32%)

FCAU

Fiat Chrysler

$21.82

-0.445 (-2.00%)

DGX

Quest Diagnostics

$105.89

5 (4.96%)

UNH

UnitedHealth

$244.96

2.23 (0.92%)

ROST

Ross Stores

$77.35

-5.6 (-6.75%)

ADSK

Autodesk

$132.80

-5.96 (-4.30%)

AAL

American Airlines

$44.89

1.34 (3.08%)

LUV

Southwest

$52.86

1.65 (3.22%)

DAL

Delta Air Lines

$55.89

1.48 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 30

    May

  • 30

    May

  • 12

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 29

    Jun

16:30
05/25/18
05/25
16:30
05/25/18
16:30
Options
Preliminary option volume of 16.4M today »

Preliminary option volume…

VTL

Vital Therapies

$5.65

-0.475 (-7.76%)

16:26
05/25/18
05/25
16:26
05/25/18
16:26
Syndicate
Breaking Syndicate news story on Vital Therapies »

Vital Therapies files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.